| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CONSENSUS STATEMENT |
Pituitary Research Unit, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
(Correspondence should be addressed to K K Y Ho; Email: k.ho{at}garvan.org.au)
Objective: The GH Research Society held a Consensus Workshop in Sydney, Australia, 2007 to incorporate the important advances in the management of GH deficiency (GHD) in adults, which have taken place since the inaugural 1997 Consensus Workshop.
Method: Two commissioned review papers, previously published Consensus Statements of the Society and key questions were circulated before the Workshop, which comprised a rigorous structure of review with breakout discussion groups. A writing group transcribed the summary group reports for drafting in a plenary forum on the last day. All participants were sent a polished draft for additional comments and gave signed approval to the final revision.
Conclusion: Testing for GHD should be extended from hypothalamic–pituitary disease and cranial irradiation to include traumatic brain injury. Testing may indicate isolated GHD; however, idiopathic isolated GHD occurring de novo in the adult is not a recognized entity. The insulin tolerance test, combined administration of GHRH with arginine or growth hormone-releasing peptide, and glucagon are validated GH stimulation tests in the adult. A low IGF-I is a reliable diagnostic indicator of GHD in the presence of hypopituitarism, but a normal IGF-I does not rule out GHD. GH status should be reevaluated in the transition age for continued treatment to complete somatic development. Interaction of GH with other axes may influence thyroid, glucocorticoid, and sex hormone requirements. Response should be assessed clinically by monitoring biochemistry, body composition, and quality of life. There is no evidence that GH replacement increases the risk of tumor recurrence or de novo malignancy.
This article has been cited by other articles:
|
|
 |
|
  A. F. Attanasio, D. Mo, E. M. Erfurth, M. Tan, K. Y. Ho, D. Kleinberg, A. G. Zimmermann, P. Chanson, and on behalf of the International Hypopituitary Contr Prevalence of Metabolic Syndrome in Adult Hypopituitary Growth Hormone (GH)-Deficient Patients Before and After GH Replacement J. Clin. Endocrinol. Metab., January 1, 2010; 95(1): 74 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Colao, C. Di Somma, S. Savastano, F. Rota, M. C. Savanelli, G. Aimaretti, and G. Lombardi A Reappraisal of Diagnosing GH Deficiency in Adults: Role of Gender, Age, Waist Circumference, and Body Mass Index J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4414 - 4422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Secco, N. di Iorgi, F. Napoli, E. Calandra, A. Calcagno, M. Ghezzi, C. Frassinetti, N. Fratangeli, S. Parodi, M. Benassai, et al. Reassessment of the Growth Hormone Status in Young Adults with Childhood-Onset Growth Hormone Deficiency: Reappraisal of Insulin Tolerance Testing J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4195 - 4204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Secco, N. di Iorgi, F. Napoli, E. Calandra, M. Ghezzi, C. Frassinetti, S. Parodi, M. R. Casini, R. Lorini, S. Loche, et al. The Glucagon Test in the Diagnosis of Growth Hormone Deficiency in Children With Short Stature Younger than 6 Years J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4251 - 4257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D J Thomas and J. P Monson Adult GH deficiency throughout lifetime Eur. J. Endocrinol., November 1, 2009; 161(suppl_1): S97 - S106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koltowska-Haggstrom, A. F Mattsson, and S. M Shalet Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations Eur. J. Endocrinol., November 1, 2009; 161(suppl_1): S51 - S64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Filipsson and G. Johannsson GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies Eur. J. Endocrinol., November 1, 2009; 161(suppl_1): S85 - S95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Klose, B Jonsson, R Abs, V Popovic, M Koltowska-Haggstrom, B Saller, U Feldt-Rasmussen, and I Kourides From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis Eur. J. Endocrinol., November 1, 2009; 161(suppl_1): S75 - S83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O. Thorner Statement by the Growth Hormone Research Society on the GH/IGF-I Axis in Extending Health Span J Gerontol A Biol Sci Med Sci, October 1, 2009; 64A(10): 1039 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cittadini, L. Saldamarco, A. M. Marra, M. Arcopinto, G. Carlomagno, M. Imbriaco, D. Del Forno, C. Vigorito, B. Merola, U. Oliviero, et al. Growth Hormone Deficiency in Patients with Chronic Heart Failure and Beneficial Effects of Its Correction J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3329 - 3336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. J. Yuen, B. M. K. Biller, M. E. Molitch, and D. M. Cook Is Lack of Recombinant Growth Hormone (GH)-Releasing Hormone in the United States a Setback or Time to Consider Glucagon Testing for Adult GH Deficiency? J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2702 - 2707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Webb, C. J. Strasburger, D. Mo, M. L. Hartman, S. Melmed, H. Jung, W. F. Blum, A. F. Attanasio, and on behalf of the HypoCCS International Advisory Bo Changing Patterns of the Adult Growth Hormone Deficiency Diagnosis Documented in a Decade-Long Global Surveillance Database J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 392 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Gasco, G Corneli, G Beccuti, F Prodam, S Rovere, J Bellone, S Grottoli, G Aimaretti, and E Ghigo Retesting the childhood-onset GH-deficient patient Eur. J. Endocrinol., December 1, 2008; 159(suppl_1): S45 - S52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Johannsson Central Adiposity as an Important Confounder in the Diagnosis of Adult Growth Hormone Deficiency J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4221 - 4223. [Full Text] [PDF]
|
|
|
|
|
|
P. Cohen, A. D. Rogol, C. L. Deal, P. Saenger, E. O. Reiter, J. L. Ross, S. D. Chernausek, M. O. Savage, J. M. Wit, and on behalf of the 2007 ISS Consensus Workshop parti Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4210 - 4217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Kopple, A. K. Cheung, J. S. Christiansen, C. B. Djurhuus, M. El Nahas, B. Feldt-Rasmussen, M. Lange, W. E. Mitch, C. Wanner, J. Wiedemann, et al. OPPORTUNITYTM: A Randomized Clinical Trial of Growth Hormone on Outcome in Hemodialysis Patients Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1741 - 1751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stojanovic, S. Pekic, G. Cvijovic, D. Miljic, M. Doknic, M. Nikolic-Djurovic, D. Micic, R. Hrvacevic, V. Nesic, and V. Popovic High Risk of Hypopituitarism in Patients Who Recovered from Hemorrhagic Fever with Renal Syndrome J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2722 - 2728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Utz, A. Yamamoto, L. Hemphill, and K. K. Miller Growth Hormone Deficiency by Growth Hormone Releasing Hormone-Arginine Testing Criteria Predicts Increased Cardiovascular Risk Markers in Normal Young Overweight and Obese Women J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2507 - 2514. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
